Clinical strategies for optimizing infusion center care through a pandemic
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical strategies for optimizing infusion center care through a pandemic
Authors
Keywords
-
Journal
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
Volume -, Issue -, Pages 107815522096021
Publisher
SAGE Publications
Online
2020-09-25
DOI
10.1177/1078155220960211
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
- (2020) Hannelore Denys et al. BREAST CANCER RESEARCH AND TREATMENT
- A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation
- (2020) Mallika Lala et al. EUROPEAN JOURNAL OF CANCER
- A portfolio of biologic self-injection devices in rheumatology: how patient involvement in device design can improve treatment experience
- (2019) Bart J. F. van den Bemt et al. DRUG DELIVERY
- Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting
- (2019) Kari M. Morrissey et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Implementation of Outpatient High-Dose Cytarabine (HiDAC) for AML: Evaluation of the Impact of Transitioned Outpatient Chemotherapy in an Oncology Care Model Setting
- (2019) Leila Jafari et al. BLOOD
- Safety of switching from intravenous to subcutaneous rituximab during first‐line treatment of patients with non‐Hodgkin lymphoma: the Spanish population of the MabRella study
- (2019) Ricardo García‐Muñoz et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy of Different Leuprolide Administration Schedules in Premenopausal Breast Cancer: A Retrospective Review
- (2018) Daniel C. Kendzierski et al. Clinical Breast Cancer
- P713 Home-based vedolizumab infusions: A suitable alternative to routine hospital infusions
- (2018) N Peek-Kuijt et al. Journal of Crohns & Colitis
- Outpatient High-dose Methotrexate for Osteosarcoma
- (2018) Eleanor Hendershot et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Ninety-minute daratumumab infusion is safe in multiple myeloma
- (2018) Hallie Barr et al. LEUKEMIA
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- (2018) Axel Grothey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
- (2018) Mark A. Socinski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
- (2018) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of nivolumab exposure and clinical safety of 480 mg every 4 weeks flat-dosing schedule in patients with cancer
- (2018) G V Long et al. ANNALS OF ONCOLOGY
- Safety profile and reduced observation time in outpatients using subcutaneous Herceptin.
- (2018) Fabiano Hosken Pombo et al. JOURNAL OF CLINICAL ONCOLOGY
- First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
- (2018) Leora Horn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trial
- (2018) Nicholas J Short et al. Lancet Haematology
- Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
- (2017) J. Gligorov et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study
- (2017) Pieternella Lugtenburg et al. HAEMATOLOGICA
- Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance)
- (2017) Charles L. Shapiro et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update
- (2017) Catherine Van Poznak et al. JOURNAL OF CLINICAL ONCOLOGY
- Trastuzumab infusion reactions in breast cancer. Should we routinely observe after the first dose?
- (2017) L Price et al. European Journal of Hospital Pharmacy-Science and Practice
- Ten-minute administration of bevacizumab
- (2017) Sara García Gil et al. European Journal of Hospital Pharmacy-Science and Practice
- Efficacy and safety of subcutaneous and intravenous rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in first-line diffuse large B-cell lymphoma: the randomized MabEase study
- (2017) Pieternella Lugtenburg et al. HAEMATOLOGICA
- Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial
- (2017) Andrew Davies et al. Lancet Haematology
- Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone
- (2017) Gabriel N. Hortobagyi et al. JAMA Oncology
- XELOXvs.FOLFOX in metastatic colorectal cancer: An updated meta-analysis
- (2016) Yu Guo et al. CANCER INVESTIGATION
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Cost savings of home bortezomib injection in patients with multiple myeloma treated by a combination care in Outpatient Hospital and Hospital care at Home
- (2016) Mohamed Touati et al. SUPPORTIVE CARE IN CANCER
- Efficacy and safety of leuprorelin acetate 6-month depot, TAP-144-SR (6M), in combination with tamoxifen in postoperative, premenopausal patients with hormone receptor-positive breast cancer: a phase III, randomized, open-label, parallel-group comparative study
- (2016) Junichi Kurebayashi et al. Breast Cancer
- Iron Supplementation for Chemotherapy-Induced Anemia in Patients Receiving Erythropoiesis-Stimulating Agents
- (2016) Rahul Mhaskar et al. JAMA Oncology
- Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study
- (2015) A. Lassalle et al. ANNALS OF ONCOLOGY
- Meta-analysis: rapid infliximab infusions are safe
- (2013) H. C. Neef et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): an open-label randomised study
- (2013) Xavier Pivot et al. LANCET ONCOLOGY
- Shorter bevacizumab infusions do not increase the incidence of proteinuria and hypertension
- (2012) S. R. Shah et al. ANNALS OF ONCOLOGY
- Monthly versus 3-monthly goserelin acetate treatment in pre-menopausal patients with estrogen receptor-positive early breast cancer
- (2011) Norikazu Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Chemotherapy-Related Hospitalization Among Community Cancer Center Patients
- (2011) M. J. Hassett et al. ONCOLOGIST
- Home care—a safe and attractive alternative to inpatient administration of intensive chemotherapies
- (2011) François Lüthi et al. SUPPORTIVE CARE IN CANCER
- Review of the Safety and Feasibility of Rapid Infusion of Rituximab
- (2010) Jill Atmar Journal of Oncology Practice
- Rapid infusion of rituximab over 60 min
- (2009) Mark Tuthill et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- A Phase I-II Study to Determine the Maximum Tolerated Infusion Rate of Rituximab with Special Emphasis on Monitoring the Effect of Rituximab on Cardiac Function
- (2008) M. Siano et al. CLINICAL CANCER RESEARCH
- Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer
- (2008) Jim Cassidy et al. JOURNAL OF CLINICAL ONCOLOGY
- Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
- (2008) Joseph A. Sparano et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search